Article Details

Q2 2022 EPS Estimates for Aptose Biosciences Inc. (NASDAQ:APTO) Increased by Analyst

Retrieved on: 2022-05-12 10:40:54

Tags for this article:

Click the tags to see associated articles and topics

Q2 2022 EPS Estimates for Aptose Biosciences Inc. (NASDAQ:APTO) Increased by Analyst. View article details on hiswai:

Excerpt

Man Group plc now owns 260,836 shares of the biotechnology company's stock worth $569,000 after buying an additional 113,456 shares during the last ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up